These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10933870)

  • 41. Association between cytochrome P450 (CYP) 2C19 polymorphisms and harm avoidance in Japanese.
    Yasui-Furukori N; Kaneda A; Iwashima K; Saito M; Nakagami T; Tsuchimine S; Kaneko S
    Am J Med Genet B Neuropsychiatr Genet; 2007 Sep; 144B(6):724-7. PubMed ID: 17357148
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Development of a semi-quantitative assay to detect full-length CYP2C19 RNA.
    Wang XY; Levy RH; Ho RJ
    Biotechniques; 2000 Aug; 29(2):364-70, 372-3. PubMed ID: 10948438
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CYP3A4-V polymorphism detection by PCR-restriction fragment length polymorphism analysis and its allelic frequency among 199 Dutch Caucasians.
    van Schaik RH; de Wildt SN; van Iperen NM; Uitterlinden AG; van den Anker JN; Lindemans J
    Clin Chem; 2000 Nov; 46(11):1834-6. PubMed ID: 11067821
    [No Abstract]   [Full Text] [Related]  

  • 44. Novel mutations of CYP3A4 in Chinese.
    Hsieh KP; Lin YY; Cheng CL; Lai ML; Lin MS; Siest JP; Huang JD
    Drug Metab Dispos; 2001 Mar; 29(3):268-73. PubMed ID: 11181494
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of genetic polymorphism of cytochrome P450 enzymes on the pharmacokinetics of benzodiazepines.
    Fukasawa T; Suzuki A; Otani K
    J Clin Pharm Ther; 2007 Aug; 32(4):333-41. PubMed ID: 17635335
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Allele frequency of CYP2C19 in a Portuguese population.
    Ruas JL; Lechner MC
    Pharmacogenetics; 1997 Aug; 7(4):333-5. PubMed ID: 9295062
    [No Abstract]   [Full Text] [Related]  

  • 47. An additional allelic variant of the CYP2D6 gene causing impaired metabolism of sparteine.
    Marez D; Legrand M; Sabbagh N; Lo-Guidice JM; Boone P; Broly F
    Hum Genet; 1996 May; 97(5):668-70. PubMed ID: 8655150
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Detection of debrisoquine hydroxylation phenotypes.
    Wolf CR; Moss JE; Miles JS; Gough AC; Spurr NK
    Lancet; 1990 Dec; 336(8728):1452-3. PubMed ID: 1978915
    [No Abstract]   [Full Text] [Related]  

  • 49. A BamHI polymorphism in the human cytochrome P450 gene, CYP2D6.
    Morimoto Y; Murayama N; Kuwano A; Yoshimura O; Kondo I
    Clin Genet; 1995 Feb; 47(2):103-4. PubMed ID: 7606840
    [No Abstract]   [Full Text] [Related]  

  • 50. Pharmacokinetics of voriconazole and cytochrome P450 2C19 genetic status.
    Ikeda Y; Umemura K; Kondo K; Sekiguchi K; Miyoshi S; Nakashima M
    Clin Pharmacol Ther; 2004 Jun; 75(6):587-8. PubMed ID: 15179414
    [No Abstract]   [Full Text] [Related]  

  • 51. The CYP3A4*3 allele: is it really rare?
    van Schaik RH; de Wildt SN; Brosens R; van Fessem M; van den Anker JN; Lindemans J
    Clin Chem; 2001 Jun; 47(6):1104-6. PubMed ID: 11375299
    [No Abstract]   [Full Text] [Related]  

  • 52. Genotyping metabolic polymorphisms in a cohort of Caucasians and single strand conformation polymorphism analysis of point mutations in human hprt exons 7 and 8.
    Krause G; Garganta F; Kosytorz P; Scherer G
    Electrophoresis; 1998 Oct; 19(14):2380-8. PubMed ID: 9820953
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of MboII polymorphism at the 5' promoter region of CYP3A4.
    Cavalli SA; Hirata MH; Hirata RD
    Clin Chem; 2001 Feb; 47(2):348-51. PubMed ID: 11159790
    [No Abstract]   [Full Text] [Related]  

  • 54. Real-time PCR-analysis of the cytochrome P450 1B1 codon 432-polymorphism.
    Brüning T; Abel J; Koch B; Lorenzen K; Harth V; Donat S; Sachinidis A; Vetter H; Bolt HM; Ko Y
    Arch Toxicol; 1999 Nov; 73(8-9):427-30. PubMed ID: 10650913
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of N-acetyltransferase 2 and CYP2C19 genotypes for hair, buccal cell swabs, or fingernails compared with blood.
    Tanigawara Y; Kita T; Hirono M; Sakaeda T; Komada F; Okumura K
    Ther Drug Monit; 2001 Aug; 23(4):341-6. PubMed ID: 11477314
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Single nucleotide polymorphism genotyping of CYP2C19 using a new automated system.
    Matsumoto N; Kakihara F; Kimura S; Kurebayashi Y; Hirai M; Yohda M; Hasegawa S
    Anal Biochem; 2007 Nov; 370(1):121-3. PubMed ID: 17603002
    [No Abstract]   [Full Text] [Related]  

  • 57. Genetic analysis of steroid-induced osteonecrosis of the femoral head.
    Asano T; Takahashi KA; Fujioka M; Inoue S; Satomi Y; Nishino H; Tanaka T; Hirota Y; Takaoka K; Nakajima S; Kubo T
    J Orthop Sci; 2003; 8(3):329-33. PubMed ID: 12768474
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mutation analysis of the human CYP3A4 gene 5' regulatory region: population screening using non-radioactive SSCP.
    Hamzeiy H; Vahdati-Mashhadian N; Edwards HJ; Goldfarb PS
    Mutat Res; 2002 Mar; 500(1-2):103-10. PubMed ID: 11890939
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetic analysis of the cytochrome P-45OIIC18 (CYP2C18) gene and a novel member of the CYP2C subfamily.
    Tsuneoka Y; Matsuo Y; Okuyama E; Watanabe Y; Ichikawa Y
    FEBS Lett; 1996 Apr; 384(3):281-4. PubMed ID: 8617372
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of DNA sequence polymorphisms in carcinogen metabolism genes by polymerase chain reaction.
    Bell DA
    Environ Mol Mutagen; 1991; 18(4):245-8. PubMed ID: 1684153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.